Chesapeake Wealth Management Catalent, Inc. Transaction History

Chesapeake Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$87.2 - $114.05 $27,119 - $35,469	-311 Reduced 4.18%	7,123 $765,000
Q1 2022 Apr 19, 2022	BUY	$94.19 - $124.49 $272,680 - $360,398	2,895 Added 63.78%	7,434 $825,000
Q4 2021 Feb 03, 2022	BUY	$119.57 - $139.07 $101,395 - $117,931	848 Added 22.97%	4,539 $581,000
Q3 2021 Oct 26, 2021	BUY	$109.17 - $142.35 $17,467 - $22,776	160 Added 4.53%	3,691 $491,000
Q2 2021 Jul 29, 2021	BUY	$100.34 - $115.69 $28,998 - $33,434	289 Added 8.91%	3,531 $382,000
Q1 2021 Apr 26, 2021	BUY	$101.51 - $125.27 $329,095 - $406,125	3,242 New	3,242 $341,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.